BIO-key International (NASDAQ:BKYI) Releases Quarterly Earnings Results, Misses Estimates By $0.16 EPS

BIO-key International (NASDAQ:BKYI) posted its quarterly earnings data on Monday, April 1st. The technology company reported ($0.10) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.06 by ($0.16), reports. The business had revenue of $1.72 million during the quarter. BIO-key International had a negative return on equity of 59.30% and a negative net margin of 169.82%.

Shares of BIO-key International stock traded down $0.05 during trading on Wednesday, reaching $1.12. The company’s stock had a trading volume of 6,332 shares, compared to its average volume of 26,548. BIO-key International has a 1-year low of $0.75 and a 1-year high of $3.64.

An institutional investor recently bought a new position in BIO-key International stock. Vanguard Group Inc bought a new position in BIO-key International, Inc. (NASDAQ:BKYI) in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 37,615 shares of the technology company’s stock, valued at approximately $52,000. Vanguard Group Inc owned about 0.27% of BIO-key International at the end of the most recent reporting period. 1.90% of the stock is currently owned by institutional investors.

A number of research firms have recently weighed in on BKYI. Maxim Group reissued a “buy” rating and issued a $4.00 price objective on shares of BIO-key International in a research report on Tuesday, April 2nd. ValuEngine cut BIO-key International from a “buy” rating to a “hold” rating in a research report on Wednesday, January 2nd.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at

BIO-key International Company Profile

BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, authentication-transaction security technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications.

Read More: What are gap-down stocks?

Earnings History for BIO-key International (NASDAQ:BKYI)

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with's FREE daily email newsletter.